Literature DB >> 921247

Comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.

T Higuchi, T Nakamura, H Uchino, G Wakisaka.   

Abstract

Leukocytes from patients with leukemia and L1210 cells from mice were examined for the rate of formation and cellular concentration of phosphoribosylpyrophosphate, the rate of thioinosinic acid formation, and a number of selected enzymes involved in purine nucleotide synthesis. The amount of thioinosinic acid formed in L1210 cells was much higher than that in human leukemic leukocytes. In cell extracts, the synthesis of thioinosinic acid was similar in both cell types, and the amount of purine phosphoribosyltransferase was not rate limiting in either case. Much higher concentrations and rates of formation of phosphoribosylpyrophosphate were found in L1210 cells than in human leukemic leukocytes. The difference in response to 6-mercaptopurine between L1210 cells and human leukemic leukocytes might be attributed to their difference in supply of phosphoribosylpyrophosphate. Phosphoribosylpyrophosphate-amidotransferase was found to be high in L1210 cells, but was not detected in human leukemic leukocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921247      PMCID: PMC429957          DOI: 10.1128/AAC.12.4.518

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM GLUCOSE IN EHRLICH ASCITES TUMOR CELLS IN VITRO.

Authors:  J F HENDERSON; M K KHOO
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

2.  PURINE NUCLEOTIDE PYROPHOSPHORYLASES IN 6-MERCAPTOPURINE-SENSITIVE AND -RESISTANT HUMAN LEUKEMIAS.

Authors:  J D DAVIDSON; T S WINTER
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

3.  INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.

Authors:  R W BROCKMAN; S CHUMLEY
Journal:  Biochim Biophys Acta       Date:  1965-03-15

4.  Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L1210 leukemia in vitro.

Authors:  J D DAVIDSON
Journal:  Cancer Res       Date:  1960-02       Impact factor: 12.701

5.  Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes.

Authors:  W A SKOOG; W S BECK
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties.

Authors:  E W Holmes; J A McDonald; J M McCord; J B Wyngaarden; W N Kelley
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

8.  Purine and pyrimidine pool sizes and purine base utilization in human lymphocytes and cultured lymphoblasts.

Authors:  T Fields; L Brox
Journal:  Can J Biochem       Date:  1974-06

9.  Human leukocyte metabolism in vitro. I. Incorporation of adenine-8-C-14 and formate-C-14 into the nucleic acids of leukemic leukocytes.

Authors:  J L SCOTT
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

10.  De novo purine biosynthesis by two pathways in Burkitt lymphoma cells and in human spleen.

Authors:  G H Reem
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.